EP3673890A1 - Medical infusion bag - Google Patents
Medical infusion bag Download PDFInfo
- Publication number
- EP3673890A1 EP3673890A1 EP18849069.2A EP18849069A EP3673890A1 EP 3673890 A1 EP3673890 A1 EP 3673890A1 EP 18849069 A EP18849069 A EP 18849069A EP 3673890 A1 EP3673890 A1 EP 3673890A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medical solution
- solution bag
- chemical
- vent hole
- accommodated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000001802 infusion Methods 0.000 title description 2
- 239000000243 solution Substances 0.000 claims abstract description 57
- 239000000126 substance Substances 0.000 claims abstract description 55
- 239000008155 medical solution Substances 0.000 claims abstract description 37
- 238000007789 sealing Methods 0.000 claims description 21
- 230000004927 fusion Effects 0.000 claims description 8
- 238000003825 pressing Methods 0.000 claims description 8
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
Definitions
- the present invention relates to a medical solution bag, and more particularly to a medical solution bag that includes an auxiliary chamber, in which a chemical is accommodated, in addition to a main chamber, in which a solution is accommodated, such that the chemical accommodated in the auxiliary chamber is easily additionally injected when the solution accommodated in the main chamber is injected as the chemical is simply mixed with the solution.
- a medical solution such as a physiological sodium chloride solution or glucose is kept in a solution container having a predetermined shape.
- the solution container is generally formed to have a bottle shape.
- the solution container having a bottle shape that is, the solution bottle is formed of glass, and because it is easily broken by an impact due to the characteristics of the material, it is difficult to treat it.
- the solution bag is formed of a flexible material such as a synthetic resin film, it is easy to treat it because it can be hardly damaged due to the characteristics of the material.
- an amino acid solution and a glucose solution are mixed and kept they are browned, if a fatty oil and an electrolyte solution are mixed and kept, the fatty components are condensed, and if a phosphoric acid-containing liquid and a calcium-containing liquid are mixed and kept, calcium phosphate is precipitated.
- a conventional medical solution bag A' having multiple chambers has a plurality of main chambers 100' that are separated and partitioned by sealing parts 11' in a body 10', the different kinds of solutions are prevented from being mixed as the solutions are accommodated in the main chambers 100', respectively.
- sealing parts 11' that separate and partition the plurality of main chambers 100' are simply separated by applying an appropriate pressure, the sealing parts 11' are separated shortly before the solutions are injected so that the mixed solutions can be injected as the different kinds of solutions accommodated in the main chambers 100', respectively, are mixed.
- the medical solution bag having multiple chambers can prevent the solutions from being mixed when being kept, but it is troublesome to additionally inject a chemical such as a vitamin agent in the solution injecting process.
- the medical solution bag having multiple chambers cannot additionally accommodate a chemical in addition to the solutions accommodated in the main chambers, and when a chemical is to be additionally injected in addition to the solutions accommodated in the main chambers, preparation of an additional member such as preparation of a separate injection needle is necessary, which is troublesome.
- the present invention has been made in an effort to solve the above-mentioned problems, and provides a medical solution bag that can solve a problem of having a troublesomeness of providing an injection needle because the injection needle has to be used when a chemical is additionally injected because a chemical except for solutions accommodated in main chambers cannot be used when a conventional medical solution bag having multiple chambers are used.
- a medical solution bag including: a main chamber in which a solution is accommodated in a bag-shaped body thereof; a main port configured to interrupt discharge of the solution from the interior to the outside of the main chamber; and an auxiliary chamber including a fixing member fixedly installed at one end of the body and communicating with the main chamber through a vent hole passing through a central portion thereof, and a storage member installed to be inserted into the vent hole of the fixing member and in which a chemical, the kind of which is different from the solution accommodated in the main chamber, is separately accommodated in an interior space thereof.
- the main chamber may be separated and partitioned by a sealing part formed to cross the interior of the body.
- the sealing part may be separated through pressing.
- the main port may be coupled to the separated/partitioned areas of the main chamber.
- the fixing member may be coupled to the body through thermal fusion or high-frequency fusion.
- the vent hole may include: an annular step formed at a circumference of an outer surface of an upper end of the vent hole; a step formed at a circumference of an inner surface of an intermediate part between the upper end and a lower end of the vent hole to protrude inwards; and a stopping step formed at a circumference of an inner surface of the lower end of the vent hole.
- the storage member may include: a cover configured to interrupt opening of an upper end of the interior space; and a cap configured to interrupt opening of a lower end of the interior space.
- the cap includes a breaking part that may be broken through pressing.
- the thickness of the breaking part may be smaller than those of the other parts.
- the storage member further may include: a stopping piece formed at a circumference of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards; and a step formed to protrude outwards.
- the auxiliary chamber may further include an O-ring configured to maintain a sealing state between the fixing member and the storage member.
- An outer surface of the auxiliary chamber may be surrounded by a light-shielding film.
- the medical solution bag according to the present invention includes an auxiliary chamber, in which a chemical is separately accommodated, in addition to main chambers, in which a solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber into the main chamber, the chemical can be easily injected in addition to the solutions.
- a medical solution bag A includes a main chamber 100, a main port 200, and an auxiliary chamber 300.
- a solution (not denoted by a reference numeral) is accommodated in a bag-shaped body 10.
- the main chamber 100 may be separated and partitioned by a sealing part 11 formed to cross the interior of the body 10.
- the sealing part 11 may be separated through pressing.
- the mixed solution may be injected.
- a plurality of sealing parts 11 may be formed, and because the number of the separated/partitioned areas of the main chamber 100 increases if the plurality of sealing parts 11 are formed, more various kinds of solutions may be accommodated through the main chamber 100.
- the main port 200 interrupts discharge of the solution from the interior to the outside of the main chamber 100.
- the main port 200 may be coupled to the separated/partitioned areas of the main chamber 100.
- the solutions accommodated in the separated/partitioned areas of the main chamber 100 may be individually injected through the main port 200.
- a main port 100 having any scheme that may interrupt discharge of the solutions accommodated in the main chamber 100 is sufficient, and an example thereof may be an injection port into which an injection needle is inserted or an infusion port into which a spike is inserted.
- the auxiliary chamber 300 includes a fixing member 310 fixedly installed at one end of the body 10 and communicating with the main chamber 100 through a vent hole 311 passing through a central portion thereof, and a storage member 320 installed to be inserted into the vent hole 311 of the fixing member 310 and in which a chemical, the kind of which is different from the solution accommodated in the main chamber 100, is separately accommodated in an interior space thereof.
- the fixing member 310 is coupled to the body 10 through thermal fusion or high-frequency fusion, leakage of the solution and the chemical through a coupling part of the fixing member 310 is prevented due to the characteristics of the coupling scheme.
- vent hole 311 of the fixing member 310 includes an annular step 311a formed at a circumference of an outer surface of an upper end thereof.
- vent hole 311 of the fixing member 310 includes a step 311b formed at a circumference of an inner surface of an intermediate portion between an upper end and a lower end thereof to protrude inwards.
- a step 324 of the storage member 320 which will be described below, is stopped by the step 311b of the fixing member 310, insertion of the storage member 320 into the vent hole 311 is restricted.
- vent hole 311 of the fixing member 310 includes a stopping step 311c formed at a circumference of an inner surface of a lower end thereof.
- a cap 321 of the storage member 320 which will be described below, drops after the cap 321 is broken and is stopped by the stopping step 311c, separation of the cap 321 from the vent hole 311 is prevented.
- the storage member 320 includes a cover 322 configured to interrupt opening of an upper end of the interior space, and a cap 321 configured to interrupt opening of a lower end of the interior space.
- the cap 321 includes a breaking part 321a that is broken through pressing.
- the chemical in the storage member 320 is simply introduced into any one of the main chambers 100 in the body 10 via the vent hole 311 of the fixing member 310.
- the thickness of the breaking part 321a is relatively small as compared with the thicknesses of the other parts, it is easily broken through pressing.
- the chemical in the storage member 320 flows downwards along a convexo-concave portion when the cap 321 is broken along the breaking part 321a as the cap 321 has the convexo-concave portion (not denoted by a reference numeral) at a circumference of an upper end thereof, the chemical is smoothly discharged even in a state in which the broken cap 321 is stopped by the stopping step 311c formed at a lower end of the vent hole 311 of the fixing member 310.
- the storage member 320 further includes a stopping piece 323 at a circumference of an outer surface of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards
- the stopping piece 323, as described above, is stopped by the annular step 311a formed at a circumference of an outer surface of an upper end of the vent hole 311 of the fixing member 310.
- the storage member 320 further includes a step 324 formed at a circumference of an outer surface of the intermediate part between the upper end and the lower end to protrude outwards.
- the step 324 is stopped by the step 311b formed at a circumference of an inner surface of the intermediate part between the upper end and the lower end of the vent hole 311 of the fixing member 310 to protrude inwards.
- the auxiliary chamber 300 further includes an O-ring 330 configured to maintain a sealing state between the fixing member 310 and the storage member 320.
- the O-ring 330 may be seated between the step 311b formed in the vent-hole 311 of the fixing member 310 and the step 324 formed in the storage member 320.
- an outer surface of the auxiliary chamber 300 may be surrounded by the light-shielding film 340.
- the light-shielding film 340 interrupts exposure of the chemical, which is accommodated in the storage member 320, to light, modification of the chemical by the exposure to light can be prevented.
- any typical material that may interrupt exposure of the chemical to light is sufficient for the light-shielding film 340, and an example thereof may be an aluminum deposited film.
- the main port 200 extends from the interior to the outside of the main chamber 100, and because an injection needle or a spike is inserted into one end of the outside of the main port 200, the solution accommodated in the main chamber 100 may be injected through the main port 200.
- the present invention includes the auxiliary chamber 300 in which the chemical is separately accommodated in addition to the main chambers 100 in which the solutions are accommodated, respectively, and because the chemical in the auxiliary chamber 300 is introduced into the main chamber 100, the chemical is easily additionally injected.
- the storage member 320 in which the chemical is accommodated, is inserted into the inside of the vent hole 311 formed to pass through a central portion of the fixing member 310 communicating with any one of the main chambers 100 of the body 10, and as illustrated in FIG. 2 , because the solutions and the chemical are mixed as the chemical in the storage member 320 is introduced into the interior of the body 10, the chemical may be additionally injected.
- the cap 321 that interrupts opening of the lower end of the interior space of the storage member 320 includes the breaking part 321a having a thickness that is smaller than the thicknesses of the other parts, and as illustrated in FIG. 5 , because the chemical in the storage member 320 is introduced into the body 10 via the vent hole 311 of the fixing member 310 as the breaking part 321a is broken, the solutions and the chemical may be simply mixed, and accordingly, the chemical may be smoothly additionally injected.
- the chemical may be leaked through a space between the fixing member 310 and the storage member 320.
- the auxiliary chamber 300 includes the O-ring 330, and because the sealing state between the fixing member 310 and the storage member 320 is maintained by the O-ring 330, leakage of the chemical through a space between the fixing member 310 and the storage member 320 is prevented.
- the cap 321 broken in the storage member 320 is separated from the fixing member 310, the additional injection of the chemical may be interfered.
- the vent hole 311 of the fixing member 310 includes the stepping step 311c formed at a circumference of the inner surface of the lower end thereof, and because the separation of the cap 321 from the fixing member 310 is prevented as the cap 321 broken in the storage member 320 is stopped by the stopping step 311c, interference with the additional injection of the chemical due to the cap 321 broken in the storage member 320 is prevented.
- the chemical accommodated in the auxiliary chamber 300 in more detail, in the storage member 320 may be modified by exposure to light.
- the outer surface of the auxiliary chamber 300 may be surrounded by the light-shielding film 340, and because exposure of the chemical accommodated in the storage member 320 to light is interrupted, modification of the chemical due to the exposure to light is prevented.
- the medical solution bag A includes the auxiliary chamber 300, in which the chemical is separately accommodated, in addition to the main chamber 100, in which the solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber 300 into the main chamber 100, the chemical can be easily additionally injected when the solution is injected.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
- The present invention relates to a medical solution bag, and more particularly to a medical solution bag that includes an auxiliary chamber, in which a chemical is accommodated, in addition to a main chamber, in which a solution is accommodated, such that the chemical accommodated in the auxiliary chamber is easily additionally injected when the solution accommodated in the main chamber is injected as the chemical is simply mixed with the solution.
- A medical solution such as a physiological sodium chloride solution or glucose is kept in a solution container having a predetermined shape.
- Then, the solution container is generally formed to have a bottle shape.
- However, the solution container having a bottle shape, that is, the solution bottle is formed of glass, and because it is easily broken by an impact due to the characteristics of the material, it is difficult to treat it.
- For this reason, in recent years, a solution container formed to have a bag shape, which is disclosed in Korean Patent Application Publication No.
10-2009-0103572 (published on October 1, 2009 - Because the solution bag is formed of a flexible material such as a synthetic resin film, it is easy to treat it because it can be hardly damaged due to the characteristics of the material.
- Meanwhile, if some solutions are mixed with other kinds of solutions when being kept, they may change over time and may become unstable.
- For example, if an amino acid solution and a glucose solution are mixed and kept they are browned, if a fatty oil and an electrolyte solution are mixed and kept, the fatty components are condensed, and if a phosphoric acid-containing liquid and a calcium-containing liquid are mixed and kept, calcium phosphate is precipitated.
- In order to solve the problems, a medical solution bag having multiple chambers has been suggested.
- Because a conventional medical solution bag A' having multiple chambers, as illustrated in
FIG. 8 , has a plurality of main chambers 100' that are separated and partitioned by sealing parts 11' in a body 10', the different kinds of solutions are prevented from being mixed as the solutions are accommodated in the main chambers 100', respectively. - Then, because the sealing parts 11' that separate and partition the plurality of main chambers 100' are simply separated by applying an appropriate pressure, the sealing parts 11' are separated shortly before the solutions are injected so that the mixed solutions can be injected as the different kinds of solutions accommodated in the main chambers 100', respectively, are mixed.
- In this way, the medical solution bag having multiple chambers can prevent the solutions from being mixed when being kept, but it is troublesome to additionally inject a chemical such as a vitamin agent in the solution injecting process.
- That is, the medical solution bag having multiple chambers cannot additionally accommodate a chemical in addition to the solutions accommodated in the main chambers, and when a chemical is to be additionally injected in addition to the solutions accommodated in the main chambers, preparation of an additional member such as preparation of a separate injection needle is necessary, which is troublesome.
- For this reason, development of a medical solution bag that can easily additionally inject a chemical in addition to solutions accommodated in main chambers by simply mixing the chemical with the solutions has been tried in the corresponding field, but a satisfactory result has not been achieved until now.
- The present invention has been made in an effort to solve the above-mentioned problems, and provides a medical solution bag that can solve a problem of having a troublesomeness of providing an injection needle because the injection needle has to be used when a chemical is additionally injected because a chemical except for solutions accommodated in main chambers cannot be used when a conventional medical solution bag having multiple chambers are used.
- In accordance with an aspect of the present invention, there is provided a medical solution bag including: a main chamber in which a solution is accommodated in a bag-shaped body thereof; a main port configured to interrupt discharge of the solution from the interior to the outside of the main chamber; and an auxiliary chamber including a fixing member fixedly installed at one end of the body and communicating with the main chamber through a vent hole passing through a central portion thereof, and a storage member installed to be inserted into the vent hole of the fixing member and in which a chemical, the kind of which is different from the solution accommodated in the main chamber, is separately accommodated in an interior space thereof.
- The main chamber may be separated and partitioned by a sealing part formed to cross the interior of the body.
- The sealing part may be separated through pressing.
- The main port may be coupled to the separated/partitioned areas of the main chamber.
- The fixing member may be coupled to the body through thermal fusion or high-frequency fusion.
- The vent hole may include: an annular step formed at a circumference of an outer surface of an upper end of the vent hole; a step formed at a circumference of an inner surface of an intermediate part between the upper end and a lower end of the vent hole to protrude inwards; and a stopping step formed at a circumference of an inner surface of the lower end of the vent hole.
- The storage member may include: a cover configured to interrupt opening of an upper end of the interior space; and a cap configured to interrupt opening of a lower end of the interior space.
- The cap includes a breaking part that may be broken through pressing.
- The thickness of the breaking part may be smaller than those of the other parts.
- The storage member further may include: a stopping piece formed at a circumference of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards; and a step formed to protrude outwards.
- The auxiliary chamber may further include an O-ring configured to maintain a sealing state between the fixing member and the storage member.
- An outer surface of the auxiliary chamber may be surrounded by a light-shielding film.
- The medical solution bag according to the present invention includes an auxiliary chamber, in which a chemical is separately accommodated, in addition to main chambers, in which a solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in the auxiliary chamber into the main chamber, the chemical can be easily injected in addition to the solutions.
-
-
FIG. 1 is a cross-sectional view illustrating a structure of a medical solution bag according to the present invention; -
FIG. 2 is an exemplary view illustrating introduction of a chemical from an auxiliary chamber to a main chamber in a medical solution bag according to the present invention; -
FIG. 3 is an exploded perspective view illustrating a structure of the auxiliary chamber in the medical solution bag according to the present invention; -
FIG. 4 is a cross-sectional view illustrating a structure of the auxiliary chamber in the medical solution bag according to the present invention; -
FIG. 5 is an exemplary view illustrating breaking of a cap from a storage chamber of the auxiliary chamber in the medical solution bag according to the present invention; -
FIG. 6 is an exemplary view illustrating an example of surrounding the auxiliary chamber by a light-shielding film in the medical solution bag according to the present invention; -
FIG. 7 is an exemplary view illustrating a form in which the main chamber is separated and partitioned by a sealing part in the medical solution bag according to the present invention; and -
FIG. 8 is a cross-sectional view illustrating a structure of the medical solution bag having multiple chambers according to the present invention. - Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
- As illustrated in
FIG. 1 , a medical solution bag A according to the present invention includes amain chamber 100, amain port 200, and anauxiliary chamber 300. - In the
main chamber 100, a solution (not denoted by a reference numeral) is accommodated in a bag-shaped body 10. - The
main chamber 100, as illustrated inFIG. 7 , may be separated and partitioned by a sealingpart 11 formed to cross the interior of thebody 10. - Accordingly, because different kinds of solutions are introduced into the separated/partitioned areas of the
main chamber 100, various kinds of solutions may be accommodated through themain chamber 100. - Then, the
sealing part 11 may be separated through pressing. - Accordingly, because different kinds of solutions are mixed as the sealing
part 11 is separated, the mixed solution may be injected. - Here, a plurality of sealing
parts 11 may be formed, and because the number of the separated/partitioned areas of themain chamber 100 increases if the plurality of sealingparts 11 are formed, more various kinds of solutions may be accommodated through themain chamber 100. - Meanwhile, because any typical structure that may easily separate the sealing
part 11 through pressing is sufficient, a detailed description of the sealingpart 11 will be omitted. - The
main port 200 interrupts discharge of the solution from the interior to the outside of themain chamber 100. - The
main port 200 may be coupled to the separated/partitioned areas of themain chamber 100. - Accordingly, the solutions accommodated in the separated/partitioned areas of the
main chamber 100 may be individually injected through themain port 200. - Meanwhile, a
main port 100 having any scheme that may interrupt discharge of the solutions accommodated in themain chamber 100 is sufficient, and an example thereof may be an injection port into which an injection needle is inserted or an infusion port into which a spike is inserted. - The
auxiliary chamber 300, as illustrated inFIGS. 3 and4 , includes afixing member 310 fixedly installed at one end of thebody 10 and communicating with themain chamber 100 through avent hole 311 passing through a central portion thereof, and astorage member 320 installed to be inserted into thevent hole 311 of thefixing member 310 and in which a chemical, the kind of which is different from the solution accommodated in themain chamber 100, is separately accommodated in an interior space thereof. - Then, because the
fixing member 310 is coupled to thebody 10 through thermal fusion or high-frequency fusion, leakage of the solution and the chemical through a coupling part of thefixing member 310 is prevented due to the characteristics of the coupling scheme. - Further, the
vent hole 311 of thefixing member 310 includes anannular step 311a formed at a circumference of an outer surface of an upper end thereof. - Accordingly, because a stopping
piece 323 of thestorage member 320, which will be described below, is stopped by theannular step 311a, thefixing member 310 and thestorage member 320 are coupled to each other. - Further, the
vent hole 311 of thefixing member 310 includes a step 311b formed at a circumference of an inner surface of an intermediate portion between an upper end and a lower end thereof to protrude inwards. - Accordingly, because a
step 324 of thestorage member 320, which will be described below, is stopped by the step 311b of thefixing member 310, insertion of thestorage member 320 into thevent hole 311 is restricted. - Further, the
vent hole 311 of thefixing member 310 includes a stoppingstep 311c formed at a circumference of an inner surface of a lower end thereof. - Accordingly, because a
cap 321 of thestorage member 320, which will be described below, drops after thecap 321 is broken and is stopped by the stoppingstep 311c, separation of thecap 321 from thevent hole 311 is prevented. - Further, the
storage member 320 includes acover 322 configured to interrupt opening of an upper end of the interior space, and acap 321 configured to interrupt opening of a lower end of the interior space. - Accordingly, leakage of the chemical through an upper end of the interior space of the
storage member 320 is prevented by thecover 322, and leakage of the chemical through a lower end of the interior space of thestorage member 320 is prevented by thecap 321 as well. - Then, because the
cover 322 is coupled to an upper end of the inside of thestorage member 320 through thermal fusion or high-frequency fusion, leakage of the chemical through a coupling part of thecover 322 is prevented due to the characteristics of the coupling scheme. - Then, the
cap 321 includes a breakingpart 321a that is broken through pressing. - Accordingly, because a lower end of the interior space of the
storage member 320 is opened if the breakingpart 321a is broken, the chemical in thestorage member 320 is simply introduced into any one of themain chambers 100 in thebody 10 via thevent hole 311 of the fixingmember 310. - Here, because the thickness of the breaking
part 321a is relatively small as compared with the thicknesses of the other parts, it is easily broken through pressing. - Meanwhile, because the chemical in the
storage member 320 flows downwards along a convexo-concave portion when thecap 321 is broken along the breakingpart 321a as thecap 321 has the convexo-concave portion (not denoted by a reference numeral) at a circumference of an upper end thereof, the chemical is smoothly discharged even in a state in which thebroken cap 321 is stopped by the stoppingstep 311c formed at a lower end of thevent hole 311 of the fixingmember 310. - Further, the
storage member 320 further includes a stoppingpiece 323 at a circumference of an outer surface of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards - Then, the stopping
piece 323, as described above, is stopped by theannular step 311a formed at a circumference of an outer surface of an upper end of thevent hole 311 of the fixingmember 310. - Further, the
storage member 320 further includes astep 324 formed at a circumference of an outer surface of the intermediate part between the upper end and the lower end to protrude outwards. - Then, the
step 324 is stopped by the step 311b formed at a circumference of an inner surface of the intermediate part between the upper end and the lower end of thevent hole 311 of the fixingmember 310 to protrude inwards. - Meanwhile, the
auxiliary chamber 300 further includes an O-ring 330 configured to maintain a sealing state between the fixingmember 310 and thestorage member 320. - Because the sealing state between the fixing
member 310 and thestorage member 320 is maintained by the O-ring 330, leakage of the chemical through a space between the fixingmember 310 and thestorage member 320 is prevented. - Then, the O-
ring 330 may be seated between the step 311b formed in the vent-hole 311 of the fixingmember 310 and thestep 324 formed in thestorage member 320. - Further, additionally, an outer surface of the
auxiliary chamber 300 may be surrounded by the light-shieldingfilm 340. - Because the light-shielding
film 340 interrupts exposure of the chemical, which is accommodated in thestorage member 320, to light, modification of the chemical by the exposure to light can be prevented. - Then, any typical material that may interrupt exposure of the chemical to light is sufficient for the light-shielding
film 340, and an example thereof may be an aluminum deposited film. - Hereinafter, injection of the solution and the chemical through the medical solution bag A according to the present invention will be described in detail.
- According to the present invention, the
main port 200 extends from the interior to the outside of themain chamber 100, and because an injection needle or a spike is inserted into one end of the outside of themain port 200, the solution accommodated in themain chamber 100 may be injected through themain port 200. - When the chemical is additionally injected in the above-described solution injecting process, a troublesomeness such as provision of an injection needle may be accompanied.
- However, the present invention includes the
auxiliary chamber 300 in which the chemical is separately accommodated in addition to themain chambers 100 in which the solutions are accommodated, respectively, and because the chemical in theauxiliary chamber 300 is introduced into themain chamber 100, the chemical is easily additionally injected. - That is, according to the present invention, the
storage member 320, in which the chemical is accommodated, is inserted into the inside of thevent hole 311 formed to pass through a central portion of the fixingmember 310 communicating with any one of themain chambers 100 of thebody 10, and as illustrated inFIG. 2 , because the solutions and the chemical are mixed as the chemical in thestorage member 320 is introduced into the interior of thebody 10, the chemical may be additionally injected. - Then, the
cap 321 that interrupts opening of the lower end of the interior space of thestorage member 320 includes the breakingpart 321a having a thickness that is smaller than the thicknesses of the other parts, and as illustrated inFIG. 5 , because the chemical in thestorage member 320 is introduced into thebody 10 via thevent hole 311 of the fixingmember 310 as the breakingpart 321a is broken, the solutions and the chemical may be simply mixed, and accordingly, the chemical may be smoothly additionally injected. - However, the chemical may be leaked through a space between the fixing
member 310 and thestorage member 320. - However, the
auxiliary chamber 300 includes the O-ring 330, and because the sealing state between the fixingmember 310 and thestorage member 320 is maintained by the O-ring 330, leakage of the chemical through a space between the fixingmember 310 and thestorage member 320 is prevented. - Further, because the
cap 321 broken in thestorage member 320 is separated from the fixingmember 310, the additional injection of the chemical may be interfered. - However, according to the present invention, the
vent hole 311 of the fixingmember 310 includes the steppingstep 311c formed at a circumference of the inner surface of the lower end thereof, and because the separation of thecap 321 from the fixingmember 310 is prevented as thecap 321 broken in thestorage member 320 is stopped by the stoppingstep 311c, interference with the additional injection of the chemical due to thecap 321 broken in thestorage member 320 is prevented. - Meanwhile, according to the present invention, the chemical accommodated in the
auxiliary chamber 300, in more detail, in thestorage member 320 may be modified by exposure to light. - However, according to the present invention, the outer surface of the
auxiliary chamber 300, as illustrated inFIG. 6 , may be surrounded by the light-shieldingfilm 340, and because exposure of the chemical accommodated in thestorage member 320 to light is interrupted, modification of the chemical due to the exposure to light is prevented. - As described above, the medical solution bag A according to the present invention includes the
auxiliary chamber 300, in which the chemical is separately accommodated, in addition to themain chamber 100, in which the solution is accommodated, and because the solutions and the chemical are simply mixed by introducing the chemical in theauxiliary chamber 300 into themain chamber 100, the chemical can be easily additionally injected when the solution is injected. - The above-described present invention is not limited to the embodiments and may be modified without departing from the essence of the present invention claimed in the claims, and the modification may fall within the scope of the present invention defined by the following description of the claims.
- 10, 10':
- body
- 11:
- sealing part
- 100, 100':
- main chamber
- 200:
- main port
- 300:
- auxiliary chamber
- 310:
- fixing member
- 311:
- vent hole
- 311a:
- annular step
- 311b:
- step
- 311c:
- stopping step
- 320:
- storage member
- 321:
- cap
- 321a:
- breaking part
- 322:
- cover
- 323:
- stopping piece
- 324:
- step
- 330:
- O-ring
- 340:
- light-shielding film
- A, A':
- medical solution bag
Claims (12)
- A medical solution bag (A, A') comprising:a main chamber (100, 100') in which a solution is accommodated in a bag-shaped body (10, 10') thereof;a main port (200) configured to interrupt discharge of the solution from the interior to the outside of the main chamber (100, 100'); andan auxiliary chamber (300) comprising a fixing member (310) fixedly installed at one end of the body (10, 10') and communicating with the main chamber (100, 100') through a vent hole (311) passing through a central portion thereof, and a storage member (320) installed to be inserted into the vent hole (311) of the fixing member (310) and in which a chemical, the kind of which is different from the solution accommodated in the main chamber (100, 100'), is separately accommodated in an interior space thereof.
- The medical solution bag of claim 1, wherein the main chamber (100, 100') is separated and partitioned by a sealing part (11) formed to cross the interior of the body (10, 10').
- The medical solution bag of claim 2, wherein the sealing part (11) is separated through pressing.
- The medical solution bag of claim 1, wherein the main port (200) is coupled to the separated/partitioned areas of the main chamber (100, 100').
- The medical solution bag of claim 1, wherein the fixing member (310) is coupled to the body (10, 10') through thermal fusion or high-frequency fusion.
- The medical solution bag of claim 1, wherein the vent hole (311) comprises:an annular step (311a) formed at a circumference of an outer surface of an upper end of the vent hole (311);a step (311b) formed at a circumference of an inner surface of an intermediate part between the upper end and a lower end of the vent hole (311) to protrude inwards; anda stopping step (311c) formed at a circumference of an inner surface of the lower end of the vent hole (311).
- The medical solution bag of claim 1, wherein the storage member (320) comprises:a cover (322) configured to interrupt opening of an upper end of the interior space; anda cap (321) configured to interrupt opening of a lower end of the interior space.
- The medical solution bag of claim 7, wherein the cap (321) comprises a breaking part (321a) that is broken through pressing.
- The medical solution bag of claim 8, wherein the thickness of the breaking part (321a) is smaller than those of the other parts.
- The medical solution bag of claim 7, wherein the storage member (320) further comprises:a stopping piece (323) formed at a circumference of the intermediate part between the upper end and the lower end to be dually folded downwards and inwards; anda step (324) formed to protrude outwards.
- The medical solution bag according to claim 1, wherein the auxiliary chamber (300) further comprises an O-ring (330) configured to maintain a sealing state between the fixing member (310) and the storage member (320).
- The medical solution bag according to claim 1, wherein an outer surface of the auxiliary chamber (300) is surrounded by a light-shielding film (340).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170107810A KR101964384B1 (en) | 2017-08-25 | 2017-08-25 | medical solution bag |
PCT/KR2018/009799 WO2019039908A1 (en) | 2017-08-25 | 2018-08-24 | Medical infusion bag |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3673890A1 true EP3673890A1 (en) | 2020-07-01 |
EP3673890A4 EP3673890A4 (en) | 2021-05-19 |
Family
ID=65439482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18849069.2A Withdrawn EP3673890A4 (en) | 2017-08-25 | 2018-08-24 | Medical infusion bag |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3673890A4 (en) |
KR (1) | KR101964384B1 (en) |
CN (1) | CN111031994A (en) |
WO (1) | WO2019039908A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102255967B1 (en) * | 2020-09-03 | 2021-05-25 | 주식회사 메디원 | tubing for injection bag mounting |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4606734A (en) * | 1984-02-22 | 1986-08-19 | Abbott Laboratories | Container mixing system with externally mounted drug container |
JP2000116749A (en) * | 1998-10-15 | 2000-04-25 | Showa Denko Kk | Transfuse container |
JP2000167022A (en) * | 1998-12-04 | 2000-06-20 | Showa Denko Kk | Double-room medical container |
JP2001009006A (en) * | 1999-06-29 | 2001-01-16 | Terumo Corp | Double cell container |
US7175614B2 (en) * | 2002-10-17 | 2007-02-13 | Baxter International Inc. | Peelable seal |
WO2006006513A1 (en) * | 2004-07-09 | 2006-01-19 | Ajinomoto Co., Inc. | Sealed article having drug stored therein |
JP4472571B2 (en) * | 2004-08-25 | 2010-06-02 | テルモ株式会社 | Cylindrical body for medical container, drug container for medical container, discharge port for medical container and medical container |
EP1838272B8 (en) * | 2004-11-26 | 2013-09-25 | Hosokawa Yoko Co., Ltd. | Medical liquid container and preparation-containing medical liquid container |
JP4956015B2 (en) * | 2006-02-21 | 2012-06-20 | テルモ株式会社 | Infusion container |
US20100327016A1 (en) * | 2007-04-05 | 2010-12-30 | Fredrick Michael Coory | Dispenser |
DE102007028733A1 (en) * | 2007-06-21 | 2008-12-24 | Fresenius Kabi Deutschland Gmbh | Container for use in enteral nutrition |
KR100946349B1 (en) | 2008-03-28 | 2010-03-08 | 이영옥 | Bag for containing medical solution |
KR101124328B1 (en) * | 2010-05-10 | 2012-03-16 | (주)메디파마플랜 | A kit of medical plastic bag having multi- chambers |
WO2012032636A1 (en) * | 2010-09-09 | 2012-03-15 | Dicプラスチック株式会社 | Two-agent mixing container |
KR101221314B1 (en) * | 2010-10-19 | 2013-01-10 | 김준배 | Liquid droplets containers |
WO2014103411A1 (en) * | 2012-12-28 | 2014-07-03 | 味の素株式会社 | Multi-chamber vessel |
KR20150002026A (en) * | 2013-06-28 | 2015-01-07 | 이상운 | Medical solution bag kit having auxiliary chamber of syringe type |
EP2962676B1 (en) * | 2014-07-02 | 2017-03-22 | Paolo Gobbi Frattini S.r.l. | Flexible package with a sealed sterile chamber for the reconstitution and administration of fluid medicinal or nutritional substances instillable into the body of a patient |
KR101611859B1 (en) * | 2015-04-24 | 2016-04-14 | 제이더블유케미타운 주식회사 | Mixable multi chamber bag |
-
2017
- 2017-08-25 KR KR1020170107810A patent/KR101964384B1/en active IP Right Grant
-
2018
- 2018-08-24 WO PCT/KR2018/009799 patent/WO2019039908A1/en unknown
- 2018-08-24 CN CN201880055199.4A patent/CN111031994A/en active Pending
- 2018-08-24 EP EP18849069.2A patent/EP3673890A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR101964384B1 (en) | 2019-04-01 |
WO2019039908A1 (en) | 2019-02-28 |
EP3673890A4 (en) | 2021-05-19 |
CN111031994A (en) | 2020-04-17 |
KR20190022058A (en) | 2019-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2214216C2 (en) | Device for connection of vessel and reservoir and system having such a device | |
US6571837B2 (en) | Transfer set for vials and medical containers | |
KR100889908B1 (en) | Medical multi-chamber container | |
RU2229871C2 (en) | Connecting device between receptacle and container and ready for use set including the same | |
US4402420A (en) | Dual function port cap | |
IL160732A (en) | Transfer device | |
WO1998030188A1 (en) | Container | |
EP2768739B1 (en) | Eyewash container | |
EP3673890A1 (en) | Medical infusion bag | |
JP3342933B2 (en) | Complete removal type container and method | |
CN107106408B (en) | Port and liquid medicine bag | |
EP0591156B1 (en) | Unit dose container | |
RU2675782C2 (en) | Container having head piece that is or can be filled with medium | |
US20230338236A1 (en) | Connector for a medical container | |
US11013663B2 (en) | Container for a medical liquid | |
EP3673889A1 (en) | Medical infusion bag | |
CN107613940B (en) | Method for manufacturing port and method for manufacturing liquid medicine bag | |
RU2770286C1 (en) | Device for temporary connection of two containers | |
US8006851B2 (en) | Child-proof capsule with a syringe doser | |
ITMI970213U1 (en) | SYRINGE FOR MEDICAL PURPOSES | |
EP4052746B1 (en) | Syringe-shaped spraying device | |
JP7428543B2 (en) | Spout with cover member | |
KR102650266B1 (en) | Safety vessel for biological tissue | |
CN104781158B (en) | Suction nozzle, the package body of band suction nozzle and the manufacture method of this package body | |
JP2006051085A (en) | Double-chamber container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200228 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HK INNO.N CORPORATION |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210419 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61J 1/20 20060101AFI20210413BHEP Ipc: A61J 1/10 20060101ALI20210413BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230523 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20231003 |